INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.73B / 25S · 14 late98 trades$31.71M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,650 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
GP
Gourmand Matthew PaulPresident
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
5,620 sh
Jun 30, 2026Jul 1, 2026
Page 593 of 1717
← PrevNext →
traded Jun 30, 2026
+1d
SEC Form 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
156 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

9
WJ
West Kenneth JPres/CEO Process Technologies
HONHONEYWELL INTERNATIONAL INC
Grant or award
A—
998 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

9
EL
Evans Terry LChief Commercial Officer
FENCFENNEC PHARMACEUTICALS INC.
Grant or award
A—
168 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

9
GP
Gourmand Matthew PaulPresident
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
5,620 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

9
MB
McGee Grant BExecutive Officer
TGTTARGET CORP
Grant or award
A—
4,127 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

9
HB
Hammoud BillalPres/CEO Building Automation
HONHONEYWELL INTERNATIONAL INC
Grant or award
A—
1,976 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

9
DJ
Drew Christopher JDirector
CTOCTO Realty Growth, Inc.
Grant or award
A$16K
779 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

9
GW
Garrett Michael WaltonChief Accounting Officer
DECDiversified Energy Co
Grant or award
A—
270 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

9
RL
Ridgway Ron LeeEVP - Energy Marketing
DECDiversified Energy Co
Grant or award
A—
527 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

9
SM
Stepniak MichalSrVP & Chief Financial Officer
HONHONEYWELL INTERNATIONAL INC
Grant or award
A—
2,494 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

9
SM
Stepniak MichalSrVP & Chief Financial Officer
HONHONEYWELL INTERNATIONAL INC
Grant or award
A—
2,493 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

9
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
67.0K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

9
WJ
West Kenneth JPres/CEO Process Technologies
HONHONEYWELL INTERNATIONAL INC
Grant or award
A—
1,976 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

9
BA
Baumeler AlfredDirector, President
SNYRSynergy CHC Corp.
Disposition to issuer
D—
150.0K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

6
SM
Seger Andrew MDirector
GABCGERMAN AMERICAN BANCORP, INC.
Grant or award
A—
1,168 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

5
PD
Paul Josh D.Chief Accounting Officer
PANWPalo Alto Networks Inc
Tax withholding · 10b5-1 plan
F$372K
1,092 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

5
PN
Puri Michal NathChief Human Resources Officer
NVCRNovoCure Ltd
Grant or award
A$21K
1,905 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

5
GV
Gupta VikasChief Investment Officer
OHIOMEGA HEALTHCARE INVESTORS INC
Option exercise
M—
5,620 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

3
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$78K
7,500 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

2
DF
Duggan John F.EXECUTIVE VICE PRESIDENT
SEMSELECT MEDICAL HOLDINGS CORP
Other acquisition or disposition · 10b5-1 plan
J—
194.7K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

1
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$246K
15.0K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

1
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$6,020
172 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

1
CK
Clark KyleDirector, SEE REMARKS
BETABETA Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$249K
15.0K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

1
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
2,500 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

0
HT
Hamilton Brian TDirector, President of CCBX
CCBCOASTAL FINANCIAL CORP
Tax withholding · 10b5-1 plan
F$18K
229 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

0
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
7,500 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M$2,530
172 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M—
172 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

0
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise · 10b5-1 plan
M—
36.3K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

50
RZ
Richmond Raphaell Z.VP, GC & Chief Compliance Off
LZBLA-Z-BOY INC
Open-market sale
SELL$545K
13.7K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

49
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market purchase
BUY$78K
600 sh
Jun 15, 2026Jun 30, 2026
traded Jun 15, 2026
+15dSEC Form 4

Evidence

44
HA
Hunt Jolie A.Director
NYSEKRCKILROY REALTY CORP
Open-market sale
SELL$597K
15.8K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

41
WE
Warren EricChief Commercial Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$2.70M
104.1K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

40
KC
Keyter CharlDirector, Chief Financial Officer
SBSWSibanye Stillwater Ltd
Open-market purchase
BUY$448K
200.0K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence

40
HT
Hudson Daniel TimothyDirector
HNRGHALLADOR ENERGY CO
Open-market purchase
BUY$85K
5,000 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

40
HT
Hudson Daniel TimothyDirector
HNRGHALLADOR ENERGY CO
Open-market purchase
BUY$85K
5,000 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC Form 4

Evidence

40
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$79K
600 sh
Jun 10, 2026Jun 30, 2026
traded Jun 10, 2026
+20dSEC Form 4

Evidence

39
PA
Pack Jay ADirector
AVOMission Produce, Inc.
Open-market purchase
BUY$484K
40.0K sh
Jun 30, 2026Jun 30, 2026
traded Jun 30, 2026
+0dSEC Form 4

Evidence

39
Topline Capital Management, LLCSee Explanation in Footnotes
NRDSNERDWALLET, INC.
Open-market sale
SELL$8.23M
919.2K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC Form 4

Evidence